Premium
Beta‐Adrenergic Blockers as a Potential Treatment for COVID‐19 Patients
Author(s) -
Vasanthakumar Natesan
Publication year - 2020
Publication title -
bioessays
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.175
H-Index - 184
eISSN - 1521-1878
pISSN - 0265-9247
DOI - 10.1002/bies.202000094
Subject(s) - medicine , ards , adrenergic , covid-19 , clinical trial , pathophysiology , intensive care medicine , disease , receptor , lung , infectious disease (medical specialty)